Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3127426
Max Phase: Preclinical
Molecular Formula: C13H11IN4OS
Molecular Weight: 398.23
Molecule Type: Small molecule
Associated Items:
ID: ALA3127426
Max Phase: Preclinical
Molecular Formula: C13H11IN4OS
Molecular Weight: 398.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NNC(=S)Nc1ccc(I)cc1)c1ccncc1
Standard InChI: InChI=1S/C13H11IN4OS/c14-10-1-3-11(4-2-10)16-13(20)18-17-12(19)9-5-7-15-8-6-9/h1-8H,(H,17,19)(H2,16,18,20)
Standard InChI Key: FLBNDYAGBWVXFJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 398.23 | Molecular Weight (Monoisotopic): 397.9698 | AlogP: 2.32 | #Rotatable Bonds: 2 |
Polar Surface Area: 66.05 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.19 | CX Basic pKa: 3.19 | CX LogP: 2.74 | CX LogD: 2.74 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.41 | Np Likeness Score: -2.51 |
1. Bhat MA, Khan AA, Khan S, Al-Omar MA, Parvez MK, Al-Dosari MS, Al-Dhfyan A.. (2014) Synthesis and anti-Candidal activity of N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl carbonyl) hydrazinecarbothioamide., 24 (5): [PMID:24513049] [10.1016/j.bmcl.2014.01.060] |
Source(1):